Missed NVDA?
Don’t Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities — for free.
LFST Stock Forecast 2026-2027
$7.25
Current Price
$2.82B
Market Cap
Buy 9
Hold 1
Sell 0
Wall St Analyst Ratings
Distance to LFST Price Targets
+37.9%
To High Target of $10.00
+17.2%
To Median Target of $8.50
+10.3%
To Low Target of $8.00
LFST Price Momentum
-2.8%
1 Week Change
+2.8%
1 Month Change
-9.3%
1 Year Change
+3.0%
Year-to-Date Change
-12.6%
From 52W High of $8.30
+93.9%
From 52W Low of $3.74
📊 TOP ANALYST CALLS
Did LFST Make This Month's Elite Buy List?
We don't follow just any analyst — only the top 3% with a proven track record make our cut. See if LifeStance is one of their latest high-conviction picks.
Latest LFST Stock Price Targets & Analyst Predictions
Based on our analysis of 13 Wall Street analysts, LFST has a bullish consensus with a median price target of $8.50 (ranging from $8.00 to $10.00). The overall analyst rating is Strong Buy (9.2/10). Currently trading at $7.25, the median forecast implies a 17.2% upside. This outlook is supported by 9 Buy, 1 Hold, and 0 Sell ratings.
The most optimistic forecast comes from David Larsen at BTIG, projecting a 37.9% upside. Conversely, the most conservative target is provided by Peter Warendorf at Barclays, suggesting a 10.3% upside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
LFST Analyst Ratings
9
Buy
1
Hold
0
Sell
LFST Price Target Range
Low
$8.00
Average
$8.50
High
$10.00
Current: $7.25
Latest LFST Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for LFST.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Dec 12, 2025 | BTIG | David Larsen | Buy | Maintains | $10.00 |
| Dec 9, 2025 | Barclays | Peter Warendorf | Overweight | Initiates | $8.00 |
| Nov 13, 2025 | BMO Capital | Sean Dodge | Outperform | Initiates | $8.00 |
| Nov 7, 2025 | UBS | Kevin Caliendo | Buy | Maintains | $10.00 |
| Nov 6, 2025 | BTIG | David Larsen | Buy | Maintains | $9.00 |
| Aug 8, 2025 | UBS | Kevin Caliendo | Buy | Maintains | $9.00 |
| May 27, 2025 | UBS | Kevin Caliendo | Buy | Upgrade | $8.50 |
| Apr 8, 2025 | Keybanc | Steve Dechert | Overweight | Initiates | $9.00 |
| Apr 3, 2025 | Canaccord Genuity | Richard Close | Buy | Initiates | $8.00 |
| Dec 16, 2024 | Goldman Sachs | Jamie Perse | Buy | Upgrade | $10.00 |
| Nov 11, 2024 | Barclays | Stephanie Davis | Underweight | Maintains | $7.00 |
| Aug 15, 2024 | UBS | Kevin Caliendo | Neutral | Maintains | $7.50 |
| Aug 9, 2024 | Barclays | Stephanie Davis | Underweight | Maintains | $6.00 |
| Apr 22, 2024 | Morgan Stanley | Ricky Goldwasser | Overweight | Reiterates | $10.00 |
| Mar 6, 2024 | Jefferies | Brian Tanquilut | Buy | Maintains | $9.00 |
| Mar 4, 2024 | Goldman Sachs | Jamie Perse | Neutral | Maintains | $9.00 |
| Feb 29, 2024 | Barclays | Underweight | Maintains | $8.00 | |
| Nov 22, 2023 | Goldman Sachs | Jamie Perse | Neutral | Maintains | $8.00 |
| Nov 17, 2023 | JP Morgan | Lisa Gill | Neutral | Maintains | $8.00 |
| Aug 10, 2023 | JP Morgan | Lisa Gill | Neutral | Maintains | $10.00 |
LifeStance Health Group, Inc. (LFST) Competitors
The following stocks are similar to LifeStance based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
LifeStance Health Group, Inc. (LFST) Financial Data
LifeStance Health Group, Inc. has a market capitalization of $2.82B with a P/E ratio of -48.3x. The company generates $1.37B in trailing twelve-month revenue with a -0.7% profit margin.
Revenue growth is +16.3% quarter-over-quarter, while maintaining an operating margin of +2.0% and return on equity of -0.6%.
Valuation Metrics
Market Cap
$2.82B
Enterprise Value
$3.16B
P/E Ratio
-48.3x
PEG Ratio
0.5x
Price/Sales
2.0x
Growth & Margins
Revenue Growth (YoY)
+16.3%
Gross Margin
+32.0%
Operating Margin
+2.0%
Net Margin
-0.7%
EPS Growth
N/A
Financial Health
Cash/Price Ratio
+7.2%
Current Ratio
1.6x
Debt/Equity
31.7x
ROE
-0.6%
ROA
+0.3%
💡 SKIP THE NOISE
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings — tracked and updated every Monday and Thursday.
LifeStance Health Group, Inc. (LFST) Business Model
About LifeStance Health Group, Inc.
What They Do
Provides comprehensive mental health services.
Business Model
The company operates by connecting patients with mental health professionals, including psychiatrists and therapists, through both in-person and telehealth services. It generates revenue by collaborating with insurance providers and healthcare systems, ensuring that patients have access to necessary psychological care while also streamlining payment processes.
Additional Information
Lifestance Health is deeply integrated within the communities it serves, addressing the increasing demand for mental health support. The company is also influential in shaping mental health policies and practices, aiming to enhance the quality of care and expand its reach in the growing behavioral health industry.
Company Information
Sector
Healthcare
Industry
Medical Care Facilities
Employees
7,996
CEO
Mr. David Patrick Bourdon
Country
United States
IPO Year
2021
Website
lifestance.comLifeStance Health Group, Inc. (LFST) Latest News & Analysis
Latest News
Wall Street Analysts Think LifeStance Health (LFST) Could Surge 30.49%: Read This Before Placing a Bet
1 month ago
Quick Summary
Analysts' price targets for LifeStance Health (LFST) suggest a 30.5% upside. Increased consensus on earnings estimates also indicates potential stock growth.
Why It Matters
Analysts' price targets suggest a significant upside for LifeStance Health (LFST), indicating potential growth, especially with raised earnings estimates reflecting positive sentiment.
Source: Zacks Investment Research
Market Sentiment:
Positive
Wall Street Analysts See a 33.38% Upside in LifeStance Health (LFST): Can the Stock Really Move This High?
2 months ago
Quick Summary
Wall Street analysts project a 33.4% upside for LifeStance Health (LFST), driven by positive earnings estimate revisions, despite mixed views on price target effectiveness.
Why It Matters
A 33.4% potential upside in price targets suggests strong growth prospects for LifeStance Health (LFST), potentially attracting investor interest and driving stock prices higher.
Source: Zacks Investment Research
Market Sentiment:
Positive
Quick Summary
LifeStance Health Group, Inc. (LFST) will hold its Q3 2025 earnings call on November 6, 2025, at 8:30 AM EST, featuring key company executives and analysts from major financial institutions.
Why It Matters
The Q3 2025 earnings call for LifeStance Health provides key insights into the company's financial performance and strategic direction, influencing investor sentiment and stock valuation.
Source: Seeking Alpha
Market Sentiment:
Neutral
LifeStance Reports Third Quarter 2025 Results
2 months ago
Quick Summary
LifeStance Health Group, Inc. (Nasdaq: LFST) reported its third-quarter financial results for the period ending September 30, 2025. Further details on the results were not included.
Why It Matters
LifeStance Health's Q3 financial results can indicate its growth potential and operational efficiency, impacting stock performance and investor sentiment in the mental healthcare sector.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Quick Summary
LifeStance Health Group (LFST) reported break-even quarterly EPS, surpassing the Zacks Consensus Estimate of a loss of $0.01, improving from a loss of $0.02 per share a year prior.
Why It Matters
LifeStance Health's break-even earnings surpass expectations, indicating potential operational improvement and investor confidence, which can positively influence stock performance.
Source: Zacks Investment Research
Market Sentiment:
Neutral
Nearly 7 in 10 Americans Feel Pressure to Appear Happier Than They Are This Holiday Season
2 months ago
Quick Summary
A LifeStance Health survey shows the holiday season significantly impacts mental health, with Millennials and Gen Z experiencing the highest levels of stress and social pressure.
Why It Matters
Increased holiday-related stress among Millennials and Gen Z may impact consumer spending, affecting retail performance and related stocks during the critical holiday season.
Source: PRNewsWire
Market Sentiment:
Neutral
Frequently Asked Questions About LFST Stock
What is LifeStance Health Group, Inc.'s (LFST) stock forecast for 2026?
Based on our analysis of 13 Wall Street analysts, LifeStance Health Group, Inc. (LFST) has a median price target of $8.50. The highest price target is $10.00 and the lowest is $8.00.
Is LFST stock a good investment in 2026?
According to current analyst ratings, LFST has 9 Buy ratings, 1 Hold ratings, and 0 Sell ratings. The stock is currently trading at $7.25. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for LFST stock?
Wall Street analysts predict LFST stock could reach $8.50 in the next 12 months. This represents a 17.2% increase from the current price of $7.25. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is LifeStance Health Group, Inc.'s business model?
The company operates by connecting patients with mental health professionals, including psychiatrists and therapists, through both in-person and telehealth services. It generates revenue by collaborating with insurance providers and healthcare systems, ensuring that patients have access to necessary psychological care while also streamlining payment processes.
What is the highest forecasted price for LFST LifeStance Health Group, Inc.?
The highest price target for LFST is $10.00 from David Larsen at BTIG, which represents a 37.9% increase from the current price of $7.25.
What is the lowest forecasted price for LFST LifeStance Health Group, Inc.?
The lowest price target for LFST is $8.00 from Peter Warendorf at Barclays, which represents a 10.3% increase from the current price of $7.25.
What is the overall LFST consensus from analysts for LifeStance Health Group, Inc.?
The overall analyst consensus for LFST is bullish. Out of 13 Wall Street analysts, 9 rate it as Buy, 1 as Hold, and 0 as Sell, with a median price target of $8.50.
How accurate are LFST stock price projections?
Stock price projections, including those for LifeStance Health Group, Inc., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Last updated: January 19, 2026 3:30 AM UTC